Thomas Chang, McGill University

Research

Anitoxidant Enzymes Catalase Superoxide Dismutase Carbonic Anhydrase Hemorrhagic Shock No Toxic Effect On The Heart Novel Soluble Biotherapeutic With No Cardiac Toxicity Tissue Carbon Dioxide Use Of Red Blood Cell Components

Latest papers

Next generation preservation solution using synthetic enzymes added to polyhemoglobin to protect warm ischemic human hepatocytes and cardiomyocytes.
Scientific reports · 2024 · senior author

All 1 publications

Latest funding

Polyhemoglobin-Catalase-SuperoxideDismutase-CarbonicAnhydrase: a novel soluble biotherapeutic with no cardiac toxicity for hemorrhagic shock and other uses.
CIHR · 2013 · Nominated PI
Novel therapeutical applications of artificial cells of macro, micron and nano dimensions as carriers in Nanomedicine and Regenerative Medicine
CIHR · 2009 · Nominated PI
$544,723
The Canadian Regenerative Medicine Network (CRM-Net) / Le Réseau Canadien de Médecine Régénérative
NSERC · 2003 · Co-investigator
$25,000

All 3 grants and awards

1 publications.

01

Next generation preservation solution using synthetic enzymes added to polyhemoglobin to protect warm ischemic human hepatocytes and cardiomyocytes.

Hoq M, Chang T

Scientific reports2024Senior author

DOI: 10.1038/s41598-024-73862-2 PMID: 39367025

Polyhemoglobin-Catalase-SuperoxideDismutase-CarbonicAnhydrase: a novel soluble biotherapeutic with no cardiac toxicity for hemorrhagic shock and other uses.

Nominated PICIHR2013Operating Grant - Priority Announcement: Blood Utilization and Conservation

Principal investigators: Chang, Thomas Ming Swi

Keywords: Anitoxidant Enzymes Catalase Superoxide Dismutase; Carbonic Anhydrase; Hemorrhagic Shock; No Toxic Effect On The Heart; Novel Soluble Biotherapeutic With No Cardiac Toxicity; Tissue Carbon Dioxide; Use Of Red Blood Cell Components

Novel therapeutical applications of artificial cells of macro, micron and nano dimensions as carriers in Nanomedicine and Regenerative Medicine

Nominated PICIHR2009Operating Grant

Principal investigators: Chang, Thomas Ming Swi

Keywords: Cardiac Ischemia; Drug Carrier For Biological Material; Melanoma; Polymeric Artificial Cells; Regenerative Medicine: Liver

$544,723

The Canadian Regenerative Medicine Network (CRM-Net) / Le Réseau Canadien de Médecine Régénérative

Co-investigatorNSERC2003Networks of Centres of Excellence

Principal investigators: Sefton, Michael

$25,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Anitoxidant Enzymes Catalase Superoxide Dismutase Dear Professor Chang, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Next generation preservation solution using synthetic enzymes added to polyhemoglobin to protect warm ischemic human hepatocytes and cardiomyocytes." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]